

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.67258833 |
| 2 | response to parathyroid hormone (GO:0071107) | 3.42656222 |
| 3 | synaptic vesicle maturation (GO:0016188) | 3.33714898 |
| 4 | cellular potassium ion homeostasis (GO:0030007) | 3.30247597 |
| 5 | regulation of ARF protein signal transduction (GO:0032012) | 3.20242342 |
| 6 | glutamate secretion (GO:0014047) | 3.11869770 |
| 7 | keratan sulfate catabolic process (GO:0042340) | 3.03389989 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 2.97958291 |
| 9 | macroautophagy (GO:0016236) | 2.97413533 |
| 10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.95016704 |
| 11 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93245140 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.84307803 |
| 13 | sodium ion export (GO:0071436) | 2.84196315 |
| 14 | iron ion import (GO:0097286) | 2.73731789 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.65125697 |
| 16 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.59949608 |
| 17 | import into cell (GO:0098657) | 2.58253410 |
| 18 | proline transport (GO:0015824) | 2.55664292 |
| 19 | detection of calcium ion (GO:0005513) | 2.52166945 |
| 20 | potassium ion import (GO:0010107) | 2.49354573 |
| 21 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.48084115 |
| 22 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.46401114 |
| 23 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.44178831 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.43893942 |
| 25 | regulation of cell communication by electrical coupling (GO:0010649) | 2.41942940 |
| 26 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.40516900 |
| 27 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.38831795 |
| 28 | positive regulation of synapse maturation (GO:0090129) | 2.33428202 |
| 29 | positive regulation of Rap GTPase activity (GO:0032854) | 2.33213858 |
| 30 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.33031280 |
| 31 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.32749972 |
| 32 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.31149606 |
| 33 | striated muscle hypertrophy (GO:0014897) | 2.30152902 |
| 34 | myofibril assembly (GO:0030239) | 2.29633932 |
| 35 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.28884505 |
| 36 | regulation of extracellular matrix disassembly (GO:0010715) | 2.27843626 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 2.27333412 |
| 38 | regulation of energy homeostasis (GO:2000505) | 2.25121391 |
| 39 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.24958345 |
| 40 | cardiac muscle contraction (GO:0060048) | 2.22531063 |
| 41 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.22528298 |
| 42 | potassium ion homeostasis (GO:0055075) | 2.21393558 |
| 43 | muscle hypertrophy (GO:0014896) | 2.21308129 |
| 44 | alanine transport (GO:0032328) | 2.20558826 |
| 45 | cellular response to epinephrine stimulus (GO:0071872) | 2.19447224 |
| 46 | cardiac muscle hypertrophy (GO:0003300) | 2.19261573 |
| 47 | cellular sodium ion homeostasis (GO:0006883) | 2.16343229 |
| 48 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.15770567 |
| 49 | regulation of synaptic vesicle transport (GO:1902803) | 2.15482581 |
| 50 | activation of protein kinase A activity (GO:0034199) | 2.14594218 |
| 51 | cellular response to ethanol (GO:0071361) | 2.14509865 |
| 52 | neurotransmitter secretion (GO:0007269) | 2.12874433 |
| 53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.12025102 |
| 54 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.11619465 |
| 55 | mannose metabolic process (GO:0006013) | 2.11527171 |
| 56 | myelin maintenance (GO:0043217) | 2.09921596 |
| 57 | relaxation of cardiac muscle (GO:0055119) | 2.09604310 |
| 58 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.09059658 |
| 59 | muscle hypertrophy in response to stress (GO:0003299) | 2.09059658 |
| 60 | cardiac muscle adaptation (GO:0014887) | 2.09059658 |
| 61 | cell communication by electrical coupling (GO:0010644) | 2.09053448 |
| 62 | positive regulation of neurotransmitter transport (GO:0051590) | 2.07913047 |
| 63 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.07717322 |
| 64 | L-amino acid import (GO:0043092) | 2.06746471 |
| 65 | actin filament capping (GO:0051693) | 2.04865009 |
| 66 | creatine metabolic process (GO:0006600) | 2.04187051 |
| 67 | regulation of beta-amyloid formation (GO:1902003) | 2.02653669 |
| 68 | cardiac conduction (GO:0061337) | 2.01974459 |
| 69 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.01202311 |
| 70 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.00737151 |
| 71 | response to epinephrine (GO:0071871) | 1.98525902 |
| 72 | negative regulation of hormone biosynthetic process (GO:0032353) | 1.98366695 |
| 73 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 1.97082420 |
| 74 | cardiac myofibril assembly (GO:0055003) | 1.97049281 |
| 75 | response to thyroid hormone (GO:0097066) | 1.96393365 |
| 76 | regulation of cholesterol homeostasis (GO:2000188) | 1.94757255 |
| 77 | adhesion of symbiont to host cell (GO:0044650) | 1.94391182 |
| 78 | virion attachment to host cell (GO:0019062) | 1.94391182 |
| 79 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 1.94166040 |
| 80 | cell communication involved in cardiac conduction (GO:0086065) | 1.93425992 |
| 81 | positive regulation of protein dephosphorylation (GO:0035307) | 1.92859484 |
| 82 | regulation of sodium ion transport (GO:0002028) | 1.92578422 |
| 83 | regulation of early endosome to late endosome transport (GO:2000641) | 1.92389892 |
| 84 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 1.92389278 |
| 85 | regulation of calcium ion transmembrane transport (GO:1903169) | 1.92389278 |
| 86 | regulation of Rap GTPase activity (GO:0032317) | 1.92174744 |
| 87 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.91278759 |
| 88 | neuromuscular process controlling posture (GO:0050884) | 1.90557099 |
| 89 | striated muscle contraction (GO:0006941) | 1.89705948 |
| 90 | actin filament depolymerization (GO:0030042) | 1.89561141 |
| 91 | trivalent inorganic cation transport (GO:0072512) | 1.89273637 |
| 92 | ferric iron transport (GO:0015682) | 1.89273637 |
| 93 | regulation of synapse maturation (GO:0090128) | 1.89144904 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 1.87973769 |
| 95 | regulation of relaxation of muscle (GO:1901077) | 1.87967430 |
| 96 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.87239371 |
| 97 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.85732848 |
| 98 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.84796268 |
| 99 | membrane depolarization during action potential (GO:0086010) | 1.84727292 |
| 100 | striated muscle adaptation (GO:0014888) | 1.84663466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.24180171 |
| 2 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.99258537 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.98692332 |
| 4 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.88133613 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.78280053 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76421708 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.74032176 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67231464 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62304613 |
| 10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58724865 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.57326449 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52379126 |
| 13 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.51971872 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.51443998 |
| 15 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.47768793 |
| 16 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47663675 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.44195821 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.43611445 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43090690 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41106259 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.40725534 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.39320996 |
| 23 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38013320 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35747240 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35639975 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33270499 |
| 27 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.32746746 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.30699867 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29760414 |
| 30 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29208212 |
| 31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28741121 |
| 32 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27951897 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.25574779 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25365147 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.24269022 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.24130458 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23395000 |
| 38 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23395000 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21545873 |
| 40 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21365940 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21162016 |
| 42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.20361943 |
| 43 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19851431 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19827069 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19381522 |
| 46 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17975303 |
| 47 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17827152 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.16760501 |
| 49 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.14050150 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12533747 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12323220 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09523154 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09523154 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06817631 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06312278 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04620485 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04544311 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04384848 |
| 59 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03756511 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03299799 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02647918 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02636169 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02571842 |
| 64 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02445622 |
| 65 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02381857 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01144871 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00422167 |
| 68 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98632601 |
| 69 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98510128 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98027804 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97810756 |
| 72 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.97783279 |
| 73 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96650551 |
| 74 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95497572 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94643828 |
| 76 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.93478745 |
| 77 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93055613 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92543890 |
| 79 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91721985 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90472595 |
| 81 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89107531 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88894733 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88663857 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88641689 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88481495 |
| 86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86915969 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85121693 |
| 88 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84593993 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.84325561 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84261430 |
| 91 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84258535 |
| 92 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.83906641 |
| 93 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.82688822 |
| 94 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82446027 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82165557 |
| 96 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82032593 |
| 97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81480080 |
| 98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81212794 |
| 99 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80993081 |
| 100 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.80275577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 2.82931309 |
| 2 | MP0005058_abnormal_lysosome_morphology | 2.45469356 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 2.40836804 |
| 4 | MP0003879_abnormal_hair_cell | 2.36336340 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.31881932 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.25855629 |
| 7 | MP0009840_abnormal_foam_cell | 2.21830900 |
| 8 | MP0003045_fibrosis | 2.16020675 |
| 9 | MP0000751_myopathy | 2.14432822 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.13360033 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.08444005 |
| 12 | MP0002998_abnormal_bone_remodeling | 1.93955328 |
| 13 | MP0004270_analgesia | 1.89825102 |
| 14 | MP0003690_abnormal_glial_cell | 1.88939936 |
| 15 | MP0004036_abnormal_muscle_relaxation | 1.81682429 |
| 16 | MP0003329_amyloid_beta_deposits | 1.81581212 |
| 17 | MP0002064_seizures | 1.81558718 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 1.71987728 |
| 19 | MP0000604_amyloidosis | 1.71521837 |
| 20 | MP0000920_abnormal_myelination | 1.67131353 |
| 21 | MP0004130_abnormal_muscle_cell | 1.63617541 |
| 22 | MP0002896_abnormal_bone_mineralization | 1.61352691 |
| 23 | MP0005503_abnormal_tendon_morphology | 1.59514287 |
| 24 | MP0003646_muscle_fatigue | 1.56507091 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.55744376 |
| 26 | MP0005365_abnormal_bile_salt | 1.53055143 |
| 27 | MP0003195_calcinosis | 1.49964532 |
| 28 | MP0001501_abnormal_sleep_pattern | 1.49705178 |
| 29 | MP0003633_abnormal_nervous_system | 1.47633663 |
| 30 | MP0003635_abnormal_synaptic_transmissio | 1.44777575 |
| 31 | MP0003279_aneurysm | 1.43747579 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.41900253 |
| 33 | MP0008569_lethality_at_weaning | 1.36614606 |
| 34 | MP0003075_altered_response_to | 1.35417070 |
| 35 | MP0005451_abnormal_body_composition | 1.33742607 |
| 36 | MP0009046_muscle_twitch | 1.32384208 |
| 37 | MP0005360_urolithiasis | 1.31146356 |
| 38 | MP0000749_muscle_degeneration | 1.27831131 |
| 39 | MP0001756_abnormal_urination | 1.26192957 |
| 40 | MP0001958_emphysema | 1.25280209 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.24905999 |
| 42 | MP0005167_abnormal_blood-brain_barrier | 1.24450164 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.24158166 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.24000011 |
| 45 | MP0004043_abnormal_pH_regulation | 1.23238178 |
| 46 | MP0005275_abnormal_skin_tensile | 1.22892376 |
| 47 | MP0000747_muscle_weakness | 1.20414957 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.20276071 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.19894576 |
| 50 | MP0005423_abnormal_somatic_nervous | 1.19324077 |
| 51 | MP0005409_darkened_coat_color | 1.18008834 |
| 52 | MP0001542_abnormal_bone_strength | 1.15175892 |
| 53 | MP0009745_abnormal_behavioral_response | 1.15174918 |
| 54 | MP0002272_abnormal_nervous_system | 1.14886173 |
| 55 | MP0003631_nervous_system_phenotype | 1.08542574 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 1.08537541 |
| 57 | MP0005670_abnormal_white_adipose | 1.07740396 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.07559500 |
| 59 | MP0002971_abnormal_brown_adipose | 1.05651325 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.04540035 |
| 61 | MP0000569_abnormal_digit_pigmentation | 1.01607166 |
| 62 | MP0004084_abnormal_cardiac_muscle | 1.00913262 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.00378183 |
| 64 | MP0006082_CNS_inflammation | 0.98544050 |
| 65 | MP0005310_abnormal_salivary_gland | 0.98156517 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 0.97574192 |
| 67 | MP0003634_abnormal_glial_cell | 0.97438556 |
| 68 | MP0004087_abnormal_muscle_fiber | 0.96723624 |
| 69 | MP0001765_abnormal_ion_homeostasis | 0.96435858 |
| 70 | MP0001502_abnormal_circadian_rhythm | 0.94650213 |
| 71 | MP0004215_abnormal_myocardial_fiber | 0.93748324 |
| 72 | MP0003795_abnormal_bone_structure | 0.93725352 |
| 73 | MP0005535_abnormal_body_temperature | 0.92996411 |
| 74 | MP0002106_abnormal_muscle_physiology | 0.91971899 |
| 75 | MP0002332_abnormal_exercise_endurance | 0.91315069 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.89271142 |
| 77 | MP0002168_other_aberrant_phenotype | 0.88777289 |
| 78 | MP0002108_abnormal_muscle_morphology | 0.88638245 |
| 79 | MP0005166_decreased_susceptibility_to | 0.87007751 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.86674786 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.85937460 |
| 82 | MP0003091_abnormal_cell_migration | 0.85914780 |
| 83 | MP0005369_muscle_phenotype | 0.84965499 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.84568891 |
| 85 | MP0000343_altered_response_to | 0.84295293 |
| 86 | MP0004484_altered_response_of | 0.84232002 |
| 87 | MP0005620_abnormal_muscle_contractility | 0.83849444 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.81913127 |
| 89 | MP0002572_abnormal_emotion/affect_behav | 0.81625317 |
| 90 | MP0008874_decreased_physiological_sensi | 0.81143399 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 0.80867701 |
| 92 | MP0002933_joint_inflammation | 0.79932147 |
| 93 | MP0005165_increased_susceptibility_to | 0.79593948 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 0.78395147 |
| 95 | MP0002972_abnormal_cardiac_muscle | 0.76804772 |
| 96 | MP0002269_muscular_atrophy | 0.75740602 |
| 97 | MP0003453_abnormal_keratinocyte_physiol | 0.74092666 |
| 98 | MP0002229_neurodegeneration | 0.73905710 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.73382220 |
| 100 | MP0003632_abnormal_nervous_system | 0.72536010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Papilledema (HP:0001085) | 5.52973089 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.88156924 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.37878993 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.37878993 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.37878993 |
| 6 | Obstructive sleep apnea (HP:0002870) | 3.12647768 |
| 7 | Dysostosis multiplex (HP:0000943) | 2.96217366 |
| 8 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92899908 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92899908 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92899908 |
| 11 | Sudden death (HP:0001699) | 2.88979903 |
| 12 | Mucopolysacchariduria (HP:0008155) | 2.86874508 |
| 13 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.86874508 |
| 14 | Neurofibrillary tangles (HP:0002185) | 2.83641395 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 2.82318350 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 2.80641597 |
| 17 | Bundle branch block (HP:0011710) | 2.80083031 |
| 18 | Abnormality of binocular vision (HP:0011514) | 2.75453494 |
| 19 | Diplopia (HP:0000651) | 2.75453494 |
| 20 | Exercise-induced myalgia (HP:0003738) | 2.70987166 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 2.67043166 |
| 22 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.62207656 |
| 23 | Overgrowth (HP:0001548) | 2.55954032 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 2.47639080 |
| 25 | Cerebral aneurysm (HP:0004944) | 2.41770592 |
| 26 | Hyporeflexia of lower limbs (HP:0002600) | 2.37483592 |
| 27 | Glomerulonephritis (HP:0000099) | 2.36255863 |
| 28 | Cerebral inclusion bodies (HP:0100314) | 2.35820100 |
| 29 | Dysmetric saccades (HP:0000641) | 2.32210446 |
| 30 | Facial diplegia (HP:0001349) | 2.31753651 |
| 31 | J-shaped sella turcica (HP:0002680) | 2.30691575 |
| 32 | Action tremor (HP:0002345) | 2.30193741 |
| 33 | Ventricular fibrillation (HP:0001663) | 2.24630161 |
| 34 | Metaphyseal dysplasia (HP:0100255) | 2.23534349 |
| 35 | Mitral stenosis (HP:0001718) | 2.23509360 |
| 36 | Mild short stature (HP:0003502) | 2.23289184 |
| 37 | Muscle fiber inclusion bodies (HP:0100299) | 2.18738591 |
| 38 | Hypophosphatemic rickets (HP:0004912) | 2.15866444 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.15388717 |
| 40 | Increased density of long bones (HP:0006392) | 2.14174120 |
| 41 | Nuclear cataract (HP:0100018) | 2.12306595 |
| 42 | Increased CSF protein (HP:0002922) | 2.10414729 |
| 43 | Nemaline bodies (HP:0003798) | 2.09514546 |
| 44 | Axonal loss (HP:0003447) | 2.07907999 |
| 45 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.04602403 |
| 46 | Febrile seizures (HP:0002373) | 2.03755141 |
| 47 | EMG: myopathic abnormalities (HP:0003458) | 1.99160720 |
| 48 | Postural instability (HP:0002172) | 1.97450555 |
| 49 | Truncal ataxia (HP:0002078) | 1.96744165 |
| 50 | Ankle clonus (HP:0011448) | 1.96677036 |
| 51 | Vertebral compression fractures (HP:0002953) | 1.95673551 |
| 52 | Abnormal atrioventricular conduction (HP:0005150) | 1.94686658 |
| 53 | Complement deficiency (HP:0004431) | 1.94326328 |
| 54 | Mutism (HP:0002300) | 1.92830369 |
| 55 | Spontaneous hematomas (HP:0007420) | 1.90855499 |
| 56 | Round ear (HP:0100830) | 1.88861076 |
| 57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.88648190 |
| 58 | Increased variability in muscle fiber diameter (HP:0003557) | 1.88097954 |
| 59 | Rigidity (HP:0002063) | 1.88021704 |
| 60 | Cardiovascular calcification (HP:0011915) | 1.87604346 |
| 61 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87198546 |
| 62 | Abnormality of the vertebral endplates (HP:0005106) | 1.86583226 |
| 63 | Heart block (HP:0012722) | 1.86517447 |
| 64 | Upper limb amyotrophy (HP:0009129) | 1.86377232 |
| 65 | Distal upper limb amyotrophy (HP:0007149) | 1.86377232 |
| 66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84294931 |
| 67 | Neuronal loss in central nervous system (HP:0002529) | 1.82904694 |
| 68 | * Craniofacial hyperostosis (HP:0004493) | 1.82239842 |
| 69 | Muscle fiber splitting (HP:0003555) | 1.82194746 |
| 70 | Vascular calcification (HP:0004934) | 1.82182435 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 1.82129673 |
| 72 | Loss of speech (HP:0002371) | 1.82038686 |
| 73 | Ventricular arrhythmia (HP:0004308) | 1.81509485 |
| 74 | Malnutrition (HP:0004395) | 1.80849047 |
| 75 | Progressive visual loss (HP:0000529) | 1.77465266 |
| 76 | Increased connective tissue (HP:0009025) | 1.77066066 |
| 77 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.76510567 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 1.76510567 |
| 79 | Hypophosphatemia (HP:0002148) | 1.76337300 |
| 80 | Hyperkalemia (HP:0002153) | 1.74553719 |
| 81 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74359964 |
| 82 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.74097009 |
| 83 | Syncope (HP:0001279) | 1.72687430 |
| 84 | Aneurysm (HP:0002617) | 1.71263056 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 1.70700318 |
| 86 | Intention tremor (HP:0002080) | 1.66984649 |
| 87 | Hand muscle atrophy (HP:0009130) | 1.66830309 |
| 88 | Spondylolisthesis (HP:0003302) | 1.66768696 |
| 89 | Difficulty running (HP:0009046) | 1.66173698 |
| 90 | Xanthomatosis (HP:0000991) | 1.65793957 |
| 91 | Aortic aneurysm (HP:0004942) | 1.65588943 |
| 92 | Prolonged QT interval (HP:0001657) | 1.65191309 |
| 93 | * Cranial hyperostosis (HP:0004437) | 1.64415538 |
| 94 | Tibial bowing (HP:0002982) | 1.62846635 |
| 95 | Ulnar deviation of the wrist (HP:0003049) | 1.62728155 |
| 96 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.62381478 |
| 97 | Subaortic stenosis (HP:0001682) | 1.62381478 |
| 98 | Spinal cord compression (HP:0002176) | 1.60597483 |
| 99 | Broad ribs (HP:0000885) | 1.60454366 |
| 100 | Depression (HP:0000716) | 1.60441665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DAPK2 | 2.53415104 |
| 2 | RIPK1 | 2.51207117 |
| 3 | PHKG1 | 2.34792768 |
| 4 | PHKG2 | 2.34792768 |
| 5 | PRPF4B | 2.18728758 |
| 6 | TTN | 2.09465414 |
| 7 | OBSCN | 1.91218641 |
| 8 | CAMKK2 | 1.87794315 |
| 9 | MAP3K13 | 1.87678026 |
| 10 | ERN1 | 1.87211669 |
| 11 | AKT3 | 1.75656865 |
| 12 | NTRK3 | 1.74855143 |
| 13 | CAMKK1 | 1.68605421 |
| 14 | MAPK12 | 1.68258187 |
| 15 | FRK | 1.60429828 |
| 16 | CAMK1D | 1.48978014 |
| 17 | TRPM7 | 1.45445929 |
| 18 | CAMK1G | 1.42291931 |
| 19 | TGFBR2 | 1.39300798 |
| 20 | TRIB3 | 1.34059218 |
| 21 | CDC42BPA | 1.29646206 |
| 22 | PAK6 | 1.24132953 |
| 23 | MAP2K6 | 1.20258177 |
| 24 | FGFR3 | 1.19219160 |
| 25 | EPHA4 | 1.17208240 |
| 26 | TNK2 | 1.16969310 |
| 27 | STK38 | 1.15174537 |
| 28 | DDR2 | 1.14608379 |
| 29 | PDPK1 | 1.13071578 |
| 30 | TAOK1 | 1.11988098 |
| 31 | SGK3 | 1.11685028 |
| 32 | MARK2 | 1.10451770 |
| 33 | MAP3K1 | 1.08982595 |
| 34 | ACVR1B | 1.07403425 |
| 35 | PDK1 | 1.06792679 |
| 36 | WNK1 | 1.06367094 |
| 37 | DMPK | 1.04676730 |
| 38 | SGK2 | 1.04598425 |
| 39 | ICK | 1.04351742 |
| 40 | PRKD3 | 1.02906709 |
| 41 | JAK1 | 1.02095286 |
| 42 | MAP3K9 | 0.99751027 |
| 43 | MAP3K7 | 0.99071999 |
| 44 | SGK223 | 0.97756923 |
| 45 | SGK494 | 0.97756923 |
| 46 | MYLK | 0.96962811 |
| 47 | LMTK2 | 0.96781254 |
| 48 | CAMK1 | 0.96053026 |
| 49 | KSR2 | 0.94532084 |
| 50 | HIPK2 | 0.93733347 |
| 51 | MAP3K3 | 0.91934822 |
| 52 | MAP3K2 | 0.89709657 |
| 53 | PDGFRA | 0.89484755 |
| 54 | MAPK7 | 0.88992176 |
| 55 | BLK | 0.87362829 |
| 56 | TESK1 | 0.86144002 |
| 57 | IRAK3 | 0.85426450 |
| 58 | PAK3 | 0.84625307 |
| 59 | PRKAA2 | 0.83353000 |
| 60 | RIPK4 | 0.82595517 |
| 61 | PRKD2 | 0.82362115 |
| 62 | CAMK4 | 0.82128101 |
| 63 | EEF2K | 0.81809723 |
| 64 | TYK2 | 0.81725062 |
| 65 | MAP2K3 | 0.80955228 |
| 66 | UHMK1 | 0.79958163 |
| 67 | SIK1 | 0.79115467 |
| 68 | PDK2 | 0.78971748 |
| 69 | MAPK11 | 0.77500371 |
| 70 | FGFR4 | 0.74960546 |
| 71 | EPHA3 | 0.73137447 |
| 72 | MAP3K11 | 0.72584548 |
| 73 | MARK1 | 0.72152866 |
| 74 | EPHB1 | 0.70968962 |
| 75 | STK11 | 0.70293808 |
| 76 | SGK1 | 0.69959825 |
| 77 | PRKCH | 0.68713358 |
| 78 | ZAP70 | 0.67119615 |
| 79 | CAMK2B | 0.65991909 |
| 80 | NLK | 0.65736293 |
| 81 | PDGFRB | 0.63309285 |
| 82 | CDK5 | 0.62672163 |
| 83 | NTRK2 | 0.60986326 |
| 84 | ARAF | 0.60762206 |
| 85 | NEK6 | 0.59943253 |
| 86 | PRKAA1 | 0.59105968 |
| 87 | RET | 0.57803344 |
| 88 | TAOK2 | 0.55229153 |
| 89 | PINK1 | 0.54502142 |
| 90 | CDK12 | 0.53654018 |
| 91 | MTOR | 0.53155061 |
| 92 | PKN2 | 0.52446588 |
| 93 | CAMK2D | 0.52159849 |
| 94 | LIMK1 | 0.51309330 |
| 95 | PTK2 | 0.50622788 |
| 96 | SIK2 | 0.49892983 |
| 97 | PIK3CG | 0.49801936 |
| 98 | MAP3K14 | 0.47687655 |
| 99 | MAP2K1 | 0.46791494 |
| 100 | MAP3K6 | 0.46424842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Insulin secretion_Homo sapiens_hsa04911 | 2.00259597 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96634955 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.91260700 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85016025 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.78056536 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 1.77979640 |
| 7 | Renin secretion_Homo sapiens_hsa04924 | 1.68553787 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48632253 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 1.47636822 |
| 10 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.46054853 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 1.41439077 |
| 12 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29018691 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.28695120 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27044288 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.25494098 |
| 16 | Mineral absorption_Homo sapiens_hsa04978 | 1.24515470 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23744827 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21629315 |
| 19 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21265715 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.17659336 |
| 21 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.16482320 |
| 22 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14976021 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.13966067 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12180398 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11876933 |
| 26 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11458414 |
| 27 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.08666677 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.07158667 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05767292 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04315124 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.03907949 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02865684 |
| 33 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02018977 |
| 34 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00265534 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00019896 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99974753 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98953238 |
| 38 | Morphine addiction_Homo sapiens_hsa05032 | 0.98383760 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97260120 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.97240142 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97137089 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97094621 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94788841 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.94646471 |
| 45 | Insulin resistance_Homo sapiens_hsa04931 | 0.93717925 |
| 46 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.92285888 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91768439 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90061939 |
| 49 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88351559 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85880507 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85309181 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82332924 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81830878 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.81140410 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80097810 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79989667 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.79795865 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79739355 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79341235 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79318398 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79188772 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76709132 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 0.74659121 |
| 64 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73678363 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73530379 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73294109 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72736747 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71941295 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.71188081 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70969773 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70801925 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.69952554 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.69609618 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.69358195 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.67610921 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66818946 |
| 77 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63331456 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63278875 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61879706 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.60135762 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59825496 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57346530 |
| 83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56954428 |
| 84 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56027645 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55905044 |
| 86 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54911943 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53327949 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.53309164 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52888723 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52395657 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50412079 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49907913 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48698084 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46503445 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46120005 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45030015 |
| 97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.43881769 |
| 98 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43747313 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43701752 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.42948323 |

